GlassScriptPhysician profile
Daphne E Hemmings
NPI 1861533325
$8,837.84
in general payments reported to CMS, 2019-2025
15 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,564 · 2020: $734 · 2021: $77.56 · 2022: $118 · 2023: $1,862 · 2024: $2,105 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,596 · Travel and Lodging: $1,724 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,596.24 |
| Travel and Lodging | $1,723.57 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,030.18 | 2019-2024 | Da Vinci Surgical System |
| Allergan, INC. | $1,979.42 | 2019-2020 | |
| Abbvie INC. | $1,139.26 | 2021-2025 | |
| Stryker Corporation | $769.74 | 2019 | |
| Medtronic, INC. | $337.04 | 2023 | Signia, Swiftset |
| Smith+Nephew, INC. | $154.24 | 2020 | |
| Covidien LP | $125.50 | 2019 | |
| Conmed Corporation | $89.53 | 2019 | |
| Pfizer INC. | $41.12 | 2019 | |
| Convatec INC. | $37.59 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $31.53 | 2020 | |
| Solventum Corporation | $30.53 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Mallinckrodt Enterprises LLC | $28.14 | 2019 | |
| Mallinckrodt Hospital Products INC. | $26.18 | 2020 | |
| Heron Therapeutics, INC. | $17.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Hemmings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.